Updated classification and management of pulmonary hypertension

Heart

Volumn 96, Issue 7, 2010, Pages 552-559

  Nef, Holger M ^a,b   Möllmann, Helge ^a   Hamm, Christian ^a   Grimminger, Friedrich ^a,b   Ghofrani, Hossein Ardeschir ^a,b  

^a Departments of Cardiology (Franz Groedel Institute) and Pneumology   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONGENITAL HEART DISEASE; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HEMOLYTIC ANEMIA; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG DISEASE; PORTOPULMONARY HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SCHISTOSOMIASIS; THROMBOEMBOLIS; CLASSIFICATION; DIAGNOSTIC IMAGING; DRUG ANTAGONISM; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART CATHETERIZATION; HUMAN; METHODOLOGY;

CARDIOVASCULAR AGENT; PROTEIN TYROSINE KINASE; SEROTONIN ANTAGONIST;

CARDIOVASCULAR AGENTS; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; PROTEIN-TYROSINE KINASES; SEROTONIN ANTAGONISTS;

EID: 77950564935     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.156299     Document Type: Review

References (25)

1. Simonneau G, Robbins I, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:43-54. ▶ Updated classification of pulmonary hypertension after the 4th World Symposium held in Dana Point 2008.
2. Ghofrani HA, Wilkins MW, Rich S. Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension. Circulation 2008;118:1195-1201 ▶ Important paper dealing with distinctive features in the diagnosis of pulmonary hypertension.
3. Galie N, Manes A, Negro L, et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 2009;30:394-403. ▶ Epidemiologic registry indicating the improved outcome of PAH patients on optimised treatment.
4. Kovacs G, Berghold A, Scheidl S, et al. Pulmonary arterial pressure during rest and exercise in healthy subjects. A systematic review. Eur Respir J 2009 34:888-894
5. Cogan JD, Pauciulo MW, Batchman AP, et al. High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension. Am J Respir Crit Care Med 2006;174:590-598
6. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:14S-34S. (Pubitemid 38932340)
7. Barst RJ (ed). Pulmonary arterial hypertension: diagnosis and evidence-based treatment. John Wiley & Sons, 2008.
8. Sitbon O, Lascoux-Combe C, Delfraissy JF, et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med 2008;177:108-113
9. Sitbon O, Beghetti M, Petit J, et al. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects. Eur J Clin Invest 2006;36 (Suppl 3):25-31. (Pubitemid 44179778)
10. Herve P, Le Pavec J, Sztrymf B, et al. Pulmonary vascular abnormalities in cirrhosis. Best Pract Res Clin Gastroenterol 2007;21:141-159
11. Lapa M, Dias B, Jardim C, et al. Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation 2009;119:1518-1523
12. Butrous G, Ghofrani HA, Grimminger F. Pulmonary vascular disease in the developing world. Circulation 2008;118: 1758-1766
13. Gladwin MT, Kato GJ. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematology Am Soc Hematol Educ Program 2005:51-57
14. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008;32:1371-e85.
15. Hoeper MM, Mayer E, Simonneau G, et al. Chronic thromboembolic pulmonary hypertension. Circulation 2006;113:2011-2020 ▶ Excellent review on the state-of-the-art management and treatment of patients with chronic thromboembolic pulmonary hypertension.
16. Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006;174:1034-1041 ▶ Important paper on TAPSE indicating its predictive value in PAH patients.
17. Vonk MC, Sander MH, van den Hoogen FH, et al. Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases. Eur J Echocardiogr 2007;8:317-321
18. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009;53:1573-1619 ▶ Expert consensus on the optimal treatment of pulmonary hypertension.
19. Sun XG, Hansen JE, Oudiz RJ, et al. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol 2003;41:1028-1035
20. Sitbon O, Humbert M, Jais X, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005;111:3105-3111 (Pubitemid 40847788)
21. Hoeper MM, Barbera JA, Channick RN, et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol 2009;54: S85-96. ▶ Nice review on pulmonary hypertension associated with left heart disease or chronic lung disease.
22. Schermuly RT, Stasch JP, Pullamsetti SS, et al. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension. Eur Respir J 2008; 32:881-891
23. Grimminger F, Weimann G, Frey R, et al. First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension. Eur Respir J 2009;33:785-792
24. Ghofrani HA, Seeger W, Grimminger F. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 2005;353:1412-1413 (Pubitemid 41362714)
25. Schermuly RT, Dony E, Ghofrani HA, et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 2005;115:2811-2821 (Pubitemid 41434408)